Proposal:

    Relationships between the Prescription Rate of 5-
α−reductase Inhibitors and the Utilization Rate of Surgic...
1.0 Introduction
Transurethral resection of the prostate (TURP) was once the standard of therapy for
benign prostatic hype...
3.1.1 Data sources for Aim 1.0
A nationwide, 5% random sample of Medicare beneficiaries will provide monthly
estimates of ...
covered by Medicare, Medicaid, private insurance, and the uninsured. Identification of
minimally invasive surgical therapi...
including both TURPs and minimally invasive surgeries, as a function of time, monthly
claims of finasteride, monthly claim...
The most straightforward approach for this aim is to use linear regression to estimate the
coefficients. The general form ...
Relationships between the Prescription Rate of 5-α− reductase
     Inhibitors and the Utilization Rate of Surgical Therapi...
AIM 2/STAGE 1

I. Preliminary Assessment of
Geographic Variations                              $9,555

Subtotal AIM 2/ STA...
Candidate for MD/MBA, Duke School of Medicine and Fuqua School of Business

Kevin A Schulman, MD, MBA
Professor of Medicin...
Appendix A: Duke Clinical Research Institute Description and Capabilities
The Duke Clinical Research Institute (DCRI) is a...
Appendix B: Curriculum Vitae of David M. Albala

                               CURRICULUM VITAE

NAME: David Mois Albala,...
1990 - 1991                Fellow in Endourology and Stone Disease, Barnes
                    Hospital,
                 ...
1994.1999            Associate Professor, Department of Urology, Loyola University,
                     Stritch School of...
PROFESSIONAL MEMBERSHIPS/COMMITTEES:
Admissions Committee—Duke University Medical School—2002-present
American Medical Fou...
Department of Urology                                       Instructor in Urology
Loyola University Medical Center        ...
Mount Ascutney Hospital, Windsor, Vermont             Emergency Room
Northeast Rehab. Hospital, Salem New Hampshire Physic...
Appalachian Mountain Club                                   Hutmaster/Hutboy
Pinkham Notch Camp                           ...
The Irving J. Shapiro Award - Dedicated to a physician who has performed outstanding
service in the urogram conference of ...
Medical Expedition to eastern Nepal with the Johns Hopkins University and the
Woodlands Institute. Involved in a health su...
Principal Investigator: David M. Albala, M.D., Co-Investigator: Mansel Kevwitch,
M.D.; Laparoscopic Ureteral Reanastomosis...
Principal Investigator: David M. Albala, M.D., Medstone STS-T: A Multi-institutional
Study. Study conducted at Loyola Univ...
Principal Investigator: John A. Heaney, M.D. Co-Investigator: David M. Albala, M.D.
Phase III - Patient preference and qua...
Urological Laparoscopy-American College of Surgeons Clinical Congress, October,
2001.

Hand Assisted Laparoscopic Urologic...
Laparoscopic Urology - Cornell University Medical Center; February, 1992; May, 1992;
September, 1992, March, 1993; October...
Kumar, U. and Albala, D.M.: Techniques in Intracorporeal Tissue Approximately:
Suturing, Newer Tissue Adhesives and Microc...
Koleski, F., Turk, T.M.T., and Albala D.M.: Carcinosarcoma of the Prostate. World
Journal of Urology 17:316, 1999

Albala,...
Mendoza, D., Neuman, R., Albala, D.M., Cohen, M., et al: Laparoscopic Complications
in Markedly Obese Urologic Patients (A...
Monk, T.G., Albala, D.M., Diaz, Y., Clayman, R.V., and White, C.F., Topical EMLA
Analgesia: Effects on Pain Response and A...
Clayman, R.V., Kavoussi, L.R., McDougall, E.M., Soper, N.J., Figenshau, R.S.,
Chandhoke, P.S. and Albala, D.M.: Laparoscop...
Albala, D.M., Danaher, J., and Huntsman, W.T.: Ventriculoperitoneal Shunt Migration
Into the Scrotum. The American Surgeon...
Griffin, J., Hatch, D. and Albala, D.M.: Laparoscopic Replacement of CAPD Catheters.
Journal of Urology.

Jahoda, J., Simo...
Kumar, U. and Albala, D.M.: Radionucleotide Imaging. Levine, D. (Ed) Urology Pearls
of Wisdom Boston Medical Publishing, B...
Albala, D.M., Chandhoke, P.S., and Clayman, R.V.: Ureterorenoscopy: Urolithiasis. In
Krane, R., Siroky, M., and Fitzpatric...
Albala, D.M., Prien, E.L., Jr., and Heaney, J.A.: Drug-Induced Urinary Lithiasis. In
Rous, S.N. (Ed.) 1990 Urology Annual....
McKay, T. and Albala, D.M.: Laparoscopic Ureteral Reanastomosis Using Fibrin Glue
(9 minutes), 1993.

Albala, D.M. and Pri...
OPERATIVE DEMONSTRATIONS:

St. Petersburg Hospital, St. Petersburg, Florida—Laparoscopic Hand-Assisted
Nephrectomy, Decemb...
Coimbatore Urological Association, Coimbatore, India - Laparoscopic Hand-Assisted
Nephrectomy, June, 2000.

All India Inst...
Massachusetts General Hospital, Boston, Massachusetts - Laparoscopic Nephrectomy,
August, 1992.


INVITED PRESENTATIONS:
D...
The Mellineum Urological Meeting, Delhi, India, November, 2000.

The 27th Annual Egyptian Urological Meeting, Cairo, Egypt...
Tampa Urological Association Meeting, Tampa, Florida, March, 1998.

American College of Surgeons 84th Clinical Congress, A...
12th World Congress of Endourology and Shock Wave Lithotripsy, St. Louis,
Missouri, December 1994.

American College of Su...
American College of Surgeons - 78th Clinical Congress, New Orleans, Louisiana,
October, 1992.

San Diego Urological Societ...
116th Annual American Public Health Association Meeting, Las Vegas, Nevada,
November, 1986.

23rd Annual Symposium of the ...
Appendix C: Curriculum Vitae of Lesley Curtis

                        DUKE UNIVERSITY MEDICAL CENTER

                   ...
Visa status (if applicable)

       Education:                    Institution                       Date
       (Year) Deg...
-2-



        Scholarly societies (Alpha Omega Alpha, Sigma Xi, Phi Beta Kappa; etc.): NA


       Professional training ...
4. Seils, DM, Castel, LD, Curtis, LH, and Weinfurt, KP. (2002). Welfare reform and
          latinas' use of perinatal hea...
Books:    (Indicate authors or editor.)



              Non-authored publications: (Faculty member formally acknowledged ...
1. “Improving patient safety: health systems reporting, analysis, and research
demonstrations.” Curtis, LH (panel particip...
-4-

         External support - gifts, grants, and contracts:

                                  EXTERNAL SUPPORT

Past S...
Clinical activity - type of practice and estimate of time commitment:


      Participation in academic and administrative...
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Glaxo.doc.doc
Upcoming SlideShare
Loading in...5
×

Glaxo.doc.doc

2,459

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
2,459
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
15
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Glaxo.doc.doc

  1. 1. Proposal: Relationships between the Prescription Rate of 5- α−reductase Inhibitors and the Utilization Rate of Surgical Therapies in the Treatment of Benign Prostatic Hyperplasia By the Duke Department of Urology1 and the Duke Center for Clinical and Genetic Economics2 Authors David M. Albala, M.D.1 Lesley H. Curtis, Ph.D.2 Jeffrey Sung Kevin A. Schulman, M.D., M.B.A.2
  2. 2. 1.0 Introduction Transurethral resection of the prostate (TURP) was once the standard of therapy for benign prostatic hyperplasia (BPH). The number of TURPs within the Medicare program peaked in 1987 when 258,000 were performed (Holtgrewe, 1998). Since then, a steady decline in the number of TURPs has accompanied improvements in the effectiveness of medical therapy and the development of less invasive surgeries (Wasson, 2000). In 1992, one of the biggest advances in the medical therapy of BPH was made with the introduction of the first 5-α−reductase inhibitor (finasteride). Prior to finasteride, medical therapy had consisted primarily of symptomatic treatment with α−blockers in an attempt to delay or avoid the necessity of surgical intervention. However, long-term studies have since shown that finasteride is capable of altering the natural history of benign prostatic hyperplasia and reducing the rates of acute urinary retention and surgery (McConnell, 1998). While TURP rates have fallen, the advancement of several minimally invasive procedures has led to the increasing use of these techniques for the treatment of BPH. Today, the most common ones include transurethral needle ablation (TUNA), transurethral microwave therapy (TUMT), interstitial laser therapy (ILT), visual laser ablation of the prostate (VLAP), transurethral vaporization of the prostate (TUEP) and high intensity focused ultrasound (HIFU). Early results for most of these therapies have shown low and acceptable re-treatment rates and shorter hospital stays (Tunuguntla, 2002). Additionally, cost-effectiveness models have suggested little difference in value between medical therapy and minimally invasive surgery for patients with moderate to severe BPH symptoms (Manyak, 2002). The question remains to what extent the increasing use of finasteride has resulted in a decrease in the utilization rate of total surgical procedures. We are pleased to provide a proposal to study this question based on the request for proposal forwarded to Dr. David Albala by GlaxoSmithKline representatives. 2.0 Research Objective and Specific Aims The overall goal of the proposed study is to examine the relationships between the prescription rate of finasteride and the utilization rates of surgical interventions for BPH. Aim 1.0. To assess the temporal relationship between the use of finasteride, TURPs, and minimally invasive surgical therapies for BPH over an eight year period from January 1, 1993 to December 31, 2000. Aim 2.0. To identify the market characteristics and socio-demographic factors associated with geographic variations in the utilization of finasteride, TURPs, and minimally invasive surgical therapies. 3.0 Research Design and Methods 3.1 Overview of Data Sources
  3. 3. 3.1.1 Data sources for Aim 1.0 A nationwide, 5% random sample of Medicare beneficiaries will provide monthly estimates of the use of TURP and minimally invasive surgical therapies in the treatment of BPH from 1993 through 2000. The file, maintained by the Health Care Financing Administration, is commonly used for research purposes. The enrollment file contains demographic information on each Medicare beneficiary, and the claims files contain expenditure and use at the individual beneficiary level for all Medicare-covered services. We will aggregate the claims on a monthly basis in order to generate monthly estimates of national estimates of the use of TURP and minimally invasive therapies. Identification of TURP will be based on the presence of Current Procedural Terminology (CPT) codes 52601, 52612, 52614, 52620 or 52630 in their hospital claims. Identification of minimally invasive surgical therapies, which will include TUNA, TUMT, ILT, VLAP, TUEP and HIFU, will be based on the presence of CPT codes 53850, 53851, 53852, 53853, 52647 or 52648 in their outpatient claims. We will obtain monthly prescription data from January 1, 1993 through December 31, 2000 from Verispan’s Source ™ Prescription Audit (SPA). SPA provides a comprehensive overview of the national performance of all prescription drugs dispensed by retail pharmacies. Each month over 140 million prescriptions are collected, projected and summed to the national level from more than 35,000 U.S. retail pharmacies, including chains, independents, mass merchandisers and food stores. Data are collected electronically at the point of pharmacy and cover nearly 70% of all dispensed prescriptions. Identification of finasteride used for benign prostatic hyperplasia will be based on the prescription of the 5 mg dosage, or NDC codes 54569-8597, 00006-0072 and 54868-2719. We will obtain corresponding prescription data for tamsulosin, the leading α−blocker, to control for its effects on surgical utilization rates. Identification of tamsulosin used for benign prostatic hyperplasia will be based on the prescription of the 0.4 mg dosage, or NDC codes 54569-4768, 00339-5560, 00597-0058, 51248-0058, 54868-4356, 12838-0058. 3.1.2 Data sources for Aim 2.0 We will use selected Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases (SIDs) in order to estimate the use of TURP at the zip code (or FIPS county code level) in the year 2000. The SIDs contain more than 100 clinical and nonclinical variables included in a hospital discharge abstract, such as principal and secondary diagnoses; principal and secondary procedures; admission and discharge status; patient demographics (e.g., gender, age, and, for some States, race); and resource utilization (total charges, length of stay). Identification of TURP will be based on the presence of CPT codes 52601, 52612, 52614, 52620 or 52630 in their hospital claims. To estimate the use of minimally invasive surgical techniques at the zip code (or FIPS county code level) in the year 2000, we will acquire selected HCUP State Ambulatory Surgical Databases (SASD). The SASD contain the ambulatory surgery encounter abstracts in participating States, translated into a uniform format to facilitate multi-state comparisons and analyses. For these encounters, the SASD captures a core set of clinical and non-clinical information on all patients, regardless of payer, including persons
  4. 4. covered by Medicare, Medicaid, private insurance, and the uninsured. Identification of minimally invasive surgical therapies, which will include TUNA, TUMT, ILT, VLAP, TUEP and HIFU, will be based on the presence of CPT codes 53850, 53851, 53852, 53853, 52647 or 52648 in their outpatient claims. For both the SID and the SASD, we will acquire data from Florida, New York, New Jersey, North Carolina and Pennsylvania. These states are 5 of the top 10 states in terms of population over age 65 and are home to approximately 26% of the nation’s elderly population. (Census 2000). In addition, the SID and SASD for these states include hospital and county identifiers that permit linkage to the American Hospital Association Annual Survey File and the Area Resource File. We will obtain data regarding finasteride dispensings at the zip code level from Verispan’s Prescription Database for the period of January 1, 2000 to December 31, 2000. Each month over 140 million prescriptions are collected from more than 35,000 U.S. retail pharmacies, including chains, independents, mass merchandisers and food stores. Data are collected electronically at the point of pharmacy and cover nearly 70% of all dispensed prescriptions. Identification of finasteride used for benign prostatic hyperplasia will be based on the prescription of the 5 mg dosage, or NDC codes 54569-8597, 00006-0072 and 54868-2719. We will obtain corresponding prescription data for tamsulosin, the leading a-blocker, to control for its effects on surgical utilization rates. Identification of tamsulosin used for benign prostatic hyperplasia will be based on the prescription of the 0.4 mg dosage, or NDC codes 54569-4768, 00339-5560, 00597-0058, 51248-0058, 54868-4356, 12838-0058. To the data from the SID, SASD, and Verispan, we will merge data from the 2000 Area Resource File (ARF). The ARF is a database containing information on health facilities, health professions, measures of resource scarcity, economic activity, and socio- demographic characteristics for each county in the U.S. 3.2 Study Time Period The analysis for Aim 1.0 will focus on an eight year period from January 1, 1993 through December 31, 2000. The time period is sufficiently long to capture necessary variations in medical therapy prescription rates and surgical procedure rates since the introduction of finasteride and those minimally invasive surgical therapies listed above. The analysis for Aim 2.0 will focus on a one year period from January 1, 2000 to December 31, 2000. This time period is sufficient for a cross-sectional study of utilization patterns of medical therapy and surgical procedures. 4.0 Research Design and Methods 4.1 General Strategy To test the hypothesis that increases in the use of finasteride have been accompanied by decreases in the use of surgical procedures, we will model total monthly surgical rates,
  5. 5. including both TURPs and minimally invasive surgeries, as a function of time, monthly claims of finasteride, monthly claims of tamsulosin, and real Medicare reimbursement levels for TURP. Additionally, to isolate the effects of all other therapies on TURPs, we will model monthly TURPs as a function of time, monthly claims of finasteride, monthly claims of tamsulosin, monthly rates for minimally invasive surgical therapies, and real Medicare reimbursement levels for TURP. To explore geographic variations in the use of finasteride, we will proceed in a two-stage process in order to ensure value for GlaxoSmithKline. In the first stage, we will calculate standard measures of variation in finasteride usage as described below in “Descriptive Analyses”. If the geographic variations meet the prespecified levels, we will continue to the second stage. In this phase, we will model annual finasteride claims at the zip code level as a function of annual claims of tamsulosin, annual TURP rates, annual rates for minimally invasive surgical therapies, and variables regarding health facilities, health professions, measures of resource scarcity, economic activity, and socio-demographic characteristics. 4.2 Descriptive Analyses In our temporal study of the period from January 1, 1993 to December 31, 2000, for each year, we will use graphical techniques to describe trends in the use of finasteride, tamsulosin, minimally invasive therapy and TURP. In our cross-sectional study of populations in New York, Florida, New Jersey, North Carolina and Pennsylvania, we will calculate standard measures of variation including the weighted coefficient of variation (COV), and the systematic component of variation (SCV). The weighted COV is the ratio of the standard deviation of the prevalence rates to the mean rate among the state, weighted by the population in each state. The SCV estimates the variance across states that cannot be explained by the variation within the state. McPherson and colleagues provide a detailed explanation of the SCV. (McPherson, 1981) In order to proceed to the second stage of analysis, we will require that the calculated values for the COV and the SCV meet or exceed the 95th percentile levels established by Diehr and colleagues generated using an iterative resampling process for various sampling schemes and prevalence rates. (Diehr, 1990) Assuming that finasteride is used by 2% of men aged 65 and older (estimated from the 1999 Medical Expenditure Panel Survey), a COV in excess of 0.05 and an SCV in excess of 8.5 would suggest that significant variation exists. 4.3 Models for Utilization Aim 1.0 requires that we model total monthly surgical utilization rates as a function of time, Medicare TURP reimbursement rates, and prescription claims for finasteride and tamsulosin. We will also model TURP rates as a function of time, Medicare TURP reimbursement rates, minimally invasive surgery rates, and prescription claims for finasteride and tamsulosin,
  6. 6. The most straightforward approach for this aim is to use linear regression to estimate the coefficients. The general form of the equation to be estimated is as follows: Yi = β 0 +∑ β j X ji +U i where Yi represents the surgical utilization rate, βo is an intercept term, the βjs are the regression coefficients relating the different variables to the surgical therapy use, and Ui is the error term. Because Aim 1.0 relies on time series data, we expect to encounter autocorrelation. That is, we expect that time series values at time t will depend on the values at another time, t-1. To account for this likely dependence, we will estimate a linear regression that is corrected for first-order serial correlation using the Prais-Winstein transformed regression estimator. (Prais and Winstein, 1954) The Prais-Winstein estimator is a generalized least squares estimator that uses an iterative process to incorporate the correlation of the residuals into coefficients. Aim 2.0 requires that we model annual finasteride claims at the county level as a function of county-level surgical utilization rates, supply of health facilities and health professionals, overall economic activity, and socio-demographic characteristics. The linear regression model is also best suited for this purpose, where Yi represents finasteride claims, βo is an intercept term, the βjs are the regression coefficients relating the different variables to the finasteride use, and Ui is the error term. One problem with applying multiple regression to the geographic data in Aim 2.0 is that geographic areas may vary considerably in population size and in the number of events of interest. (Pocock, 1981) Areas with large populations provide the most reliable estimates and should therefore be weighted more heavily. In this analysis, we will use a weighting procedure developed by Pocock et al. that uses the relative contribution of sampling error to the unexplained variation between counties to determine weights. (Pocock, 1981) 5.0 Deliverables Based on the results of Aim 1, one manuscript will be prepared for submission to a professional journal. Assuming sufficient variation in finasteride use is found in stage one of Aim 2, a second manuscript will be prepared for submission to a professional journal. In addition, A report of the overall analyses with discussion will be submitted to the sponsor. 6.0 Project Budget The budget for Aim 1, inclusive of data acquisition costs, is $ 134,843. The budget for Aim 2, inclusive of data acquisition costs, is $122,180. Travel time and travel expenses are not included.
  7. 7. Relationships between the Prescription Rate of 5-α− reductase Inhibitors and the Utilization Rate of Surgical Therapies in the Treatment of Benign Prostatic Hyperplasia Tasks AIM 1 I. Start Up/Literature Review/ IRB Preparation and Submission $5,985 II. Data Acquisition $43,600 III. Data Processing $4,485 IV. Data Analysis $25,225 V. Manuscript $25,805 Subtotal AIM 1 $105,100 Indirect Costs @ 28.3% $29,743 Total Costs AIM 1 $134,843
  8. 8. AIM 2/STAGE 1 I. Preliminary Assessment of Geographic Variations $9,555 Subtotal AIM 2/ STAGE 1 $9,555 Indirect Costs @ 28.3% $2,704 Total Costs AIM 2/ STAGE 1 $12,259 AIM 2/ STAGE 2 I. Literature Review $4,485 II. Data Acquisition $22,410 III. Data Processing $13,535 IV. Data Analysis $28,995 V. Manuscript $25,805 Subtotal AIM 2/STAGE 2 $95,230 Indirect Costs @ 28.3% $26,950 Total Costs AIM 2/STAGE 2 $122,180 7.0 Project Timeline Estimated Project Start Date: August 1, 2003 Timeline: Planning/Startup 1.5 Months August 1, 2003 – September 15, 2003 Data Preparation 3.5 Months September 15, 2003 – January 15, 2004 Statistical Analysis 4.5 Months January 15, 2004 – June 1, 2004 Manuscripts 2.5 Months June 1, 2004 – July 31, 2004 Total Timeline: 12 Months August 1, 2003 – July 31, 2004 8.0 Collaborators This proposal brings together a multi-disciplinary team with considerable expertise in urology, economics, health services research and policy analysis. Collaborators include: David M. Albala, MD Professor of Urology, Duke University Medical Center Lesley H. Curtis, PhD, MS Research Associate and Director, CERTs Data Center, Duke Clinical Research Institute Jeffrey C. Sung
  9. 9. Candidate for MD/MBA, Duke School of Medicine and Fuqua School of Business Kevin A Schulman, MD, MBA Professor of Medicine, Duke University Medical Center Professor of Business Administration, Fuqua School of Business, Duke University Director, Center for Clinical and Genetic Economics, Duke Clinical Research Institute 9.0 References Diehr P, Cain K, Connell F, Volinn E. What is too much variation? The null hypothesis in small-area analysis. Health Services Research 1990;24:741-771. Holtgrewe, HL. Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia. Urology 51 (Suppl 4A): 1-7, 1998. Manyak, MJ, Ackerman, SJ, Blute, ML, et al. Cost effectiveness of treatment for benign prostatic hyperplasia: An economic model for comparison of medical, minimally invasive, and surgical therapy. Journal of Endourology 16:1, February 2002. McConnell, JD, Bruskewitz, R, Walsh, P, et al, and the Finasteride Long-Term Efficacy and Safety Study Group: The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. New England Journal of Medicine 338: 557-563, 1998. McPherson K, Strong PM, Epstein A, Jones L. Regional variations in the use of common surgical procedures: within and between England and Wales, Canada and the United States of Americal. Soc Sci Med [A]. 1981;15(3 pt 1):273-288. Pocock S, Cook D, Beresford S. Regression of area mortality rates on explanatory variables: What weighting is appropriate? Applied Statistics 1981;30:286-95. Prais SJ, Winstein CB. Trend estimators and serial correlation. (1954) Cowle Commission Discussion Paper No. 383. Chicago, IL. Tunuguntla, HS, Evans, CP. Minimally invasive therapies for benign prostatic hyperplasia. World Journal of Urology 20: 197-206, 2002. Wasson, JH, Bubolz, TA, Lu-Yao, GL, Walker-Corkery, E, Hammond, CS and Barry, MJ for the PORT for Prostatic Diseases. Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. The Journal of Urology 164: 1212-1215, October 2000.
  10. 10. Appendix A: Duke Clinical Research Institute Description and Capabilities The Duke Clinical Research Institute (DCRI) is a full-service contract research organization committed to an academic mission, yet focused on customer service. True to our academic foundation, our mission is “To develop and share knowledge that improves the care of patients around the world through innovative clinical research.” Specifically, we believe that our organization’s fundamental motivation must be to improve care for patients by promoting an evidence-based approach to health care via clinical trials and outcomes research. Fidelity to this mission has allowed our organization to gain considerable research credibility, rivaling the best commercial research organizations in the world. The DCRI designs and conducts large and small multinational clinical studies, and we employ over 750 people to ensure the flexibility to meet the needs of all current projects and this proposal. We maintain the oldest and largest cardiovascular database in the world and have conducted the largest thrombolytic trial in history (41,021 patients in 15 countries). We have conducted over 75 clinical trials, involving 4200 investigators at over 3120 sites in more than 50 countries. Overall, we have enrolled more than 180,000 patients in clinical trials. We have expanded our capabilities steadily over the past decade and have an extensive faculty and staff experienced in the conduct of clinical trials, capable of running multiple large and small studies simultaneously. We are organized into functional groups— including a world-renowned group of outcomes and health services researchers— designed to maximize performance in our core research areas of clinical investigative trials, outcomes studies, registries, and data base analyses. The DCRI’s Center for Clinical and Genetic Economics (CCGE) and its Outcomes Research and Assessment Group has 26 full-time faculty and over 80 full-time support staff devoted solely to outcomes research, including clinicians, health economists, statisticians, and health services researchers. This group leads the nation in the collection of economic and quality of life data for clinical research and has so far conducted over 20 large-scale economic and quality of life studies alongside randomized controlled trials. With this impressive array of resources, the DCRI is uniquely poised as an international leader in applying quantitative measurements and methods to clinical research and the practice of medicine. The DCRI fills this role efficiently and cost-effectively, while remaining a customer-focused and performance-driven organization.
  11. 11. Appendix B: Curriculum Vitae of David M. Albala CURRICULUM VITAE NAME: David Mois Albala, M.D., F.A.C.S. HOME ADDRESS: OFFICE ADDRESS: 904 Bayberry Drive Duke University Medical Center Chapel Hill, NC 27517 Department of Surgery (919) 942-9415 Division of Urology E-mail: dmalbala@aol.com DUMC Box 3457 Rm. 1112 Green Zone Davison Bldg. Trent Drive Durham, NC 27710 (919) 684-5416 (Direct Line) (919) 681-7423 (Fax) E-mail: albal002@mc.duke.edu WIFE: Francine A. Salerno 10/23/99 DATE AND PLACE OF BIRTH: December 29, 1955; Chicago, IL SOCIAL SECURITY NUMBER: 035-40-5462 EDUCATION: Michigan State University M.D. College of Human Medicine June 1983 East Lansing, Michigan 48824 Brown University Program in Medicine Student Providence, Rhode Island 02912 1979 - 1981 Lafayette College A.B. Honors in Geology Easton, Pennsylvania 18042 June 1978 Harvard University Visiting Scholar Cambridge, Massachusetts 02138 1977 Kings College English Speaking Union Taunton, Somerset, England Scholarship, 1974 POST DOCTORAL TRAINING:
  12. 12. 1990 - 1991 Fellow in Endourology and Stone Disease, Barnes Hospital, Washington University School of Medicine, St. Louis, Missouri 63108 (under the direction of Ralph V. Clayman, M.D.) 1989 - 1990 Chief Resident, Urology, Dartmouth-Hitchcock Medical Center Hanover, New Hampshire 03756 1989 Senior Resident, Pediatric Urology, Massachusetts (Jan-March) General Hospital Boston, Massachusetts 02114 (under the direction of Patricia K. Donahoe, MD) 1988 - 1989 Senior Resident, Urology, Dartmouth-Hitchcock Medical Center Hanover, New Hampshire 03756 1987 - 1988 Research Resident, Urology, Dartmouth-Hitchcock Medical Center Hanover, New Hampshire 03756 (area of concentration: drug-induced nephrolithiasis) 1986 - 1987 Junior Resident, Urology, Dartmouth-Hitchcock Medical Center Hanover, New Hampshire 03756 1984 - 1985 Junior Resident, General Surgery, Dartmouth-Hitchcock Medical Center Hanover, New Hampshire 03756 1983 -1984 Intern, General Surgery, Dartmouth-Hitchcock Medical Center Hanover, New Hampshire 03756 ACADEMIC APPOINTMENT: 2001-Present Professor, Divison of Urology, Duke University Medical Center, Durham, North Carolina 27710 2001-Present Staff Urologist, Veterans Administration Hospital, Durham, North Carolina 27710 1999-2001 Professor, Department of Urology and Radiology, Loyola University, Strich School of Medicine, Maywood, Illinois 60153 1991-2001 Staff Urologist, Veterans Administration Hospital Hines, Illinois 60141
  13. 13. 1994.1999 Associate Professor, Department of Urology, Loyola University, Stritch School of Medicine, Maywood, Illinois 60153 1995-1996 Associate Professor, Department of Urology, George Washington Medical Center, Washington, DC 20008 1992.1994 Assistant Professor, Department of Urology, Loyola University Stritch School of Medicine, Maywood, Illinois 60153 1991-1992 Instructor, Department of Urology, Loyola University Stritch School of Medicine, Maywood, Illinois 60153 1990-1991 Clinical Fellow (Urology), Washington University School of Medicine, St. Louis, Missouri 63110 1989-1990 Clinical Instructor (Urology), Dartmouth Medical School, Hanover, New Hampshire 03756 FELLOWSHIP DIRECTOR: 2001-Present Co-Director of the Duke University Endourology Fellowship Program, approved by the Endourological Society 1996-2001 Director of The Loyola University Endourology Fellowship Program, approved by the Endourological Society LICENSURE/CERTIFICATION: State of North Carolina, 2001-current (2002-01164) State of New Hampshire, 1984 - 2002 (#7609) State of Illinois, 1991-2002 (036-083171) State of New York, 1993 - 1995 (193729) State of Vermont, 1984 - 1998 (#42-0007234) State of Missouri, 1990-1991 (T-17094) State of Massachusetts, 1989 - 1990 (#967768) Basic Cardiac Life Support - 1984 - current Advanced Trauma Life Support - 1984 - current Advanced Cardiac Life Support Instructor - 1986 - current Advanced Life Support - 1985 - current Federal Licensing Examination (FLEX) - 1984 Extracorporeal Shock Wave Lithotripsy (Dornier)- Mass. General Hosp. 1989 Extracorporeal Shock Wave Lithotripsy (Lithostar) - Barnes Hospital - 1990 Urological Laser Certification - Pulse-Dye, Nd-Yag, Indigo, Holmium, CO2-1991 American Board of Urology (Parts I and II) - certified- 1994; re-certified 2001
  14. 14. PROFESSIONAL MEMBERSHIPS/COMMITTEES: Admissions Committee—Duke University Medical School—2002-present American Medical Foundation - 2000 -present American Urological Association - 1986-present American College of Surgeons (Fellow) - 1988 -present American Medical Association - 1988-present American Association for the Advancement of Science - 1989-present American Public Health Association - 1985-present Endourological Society - 1990-present Society for Minimally Invasive Therapy - 1991-present American Association of Clinical Urologists - 1992-present Society of University Urologists - 1992-present Societe Internationale d'Urologie - 1993-present Society for Urology and Engineering - 1992 - present Medical Advisory Committee - American Telemedicine - 1993-present Admission Committee - Loyola Stritch School of Medicine 1994-2001 Medical Record Committee - Loyola University Med. Ctr. - 1993-2001 Surgical Pathology Committee Loyola University Med. Ctr. - 1992-2001 Health Policy Committee, American Urological Association - 1995-1998, 2000-2001 Chicago Urological Society - 1991-2001 Executive Committee - Chicago Urological Society - 1996-2001 Illinois State Urological Society - 1991 -2001 Loyola University Physician Foundation (LUPF) Board Member - 1997-2000 Medical Advisory Committee - Day Surgi Center - 1993-1996 Blood Usage Committee - Loyola University Med. Ctr. - 1992-1998 Grafton County Medical Society - 1986-1990 New Hampshire Urological Society - 1986-1990 Appalachian Mountain Club - Search and Rescue Committee - 1983-1990 Health Advisory Committee - Vermont March of Dimes - 1989-1990 EMPLOYMENT: Division of Urology Professor of Urology Duke University Medical Center 2001-Present Room 1112, Green Zone, DUMC Box 3457 Durham, NC 27710 Director of minimally invasive urologic surgery at a large academic teaching hospital. Involved with endoscopic and laparoscopic surgery, patient care, and resident/medical student education. Engaged in all aspects of laparoscopic and endourological research.
  15. 15. Department of Urology Instructor in Urology Loyola University Medical Center 1991-1992 Stritch School of Medicine Assistant Professor of Urology 2160 South First Avenue 1992-1994 Maywood, Illinois 60153 Associate Professor of Urology 1994-1999 Professor of Urology and Radiology 1999-2001 Responsible for the Endourology service at an academic teaching hospital. Involved with endoscopic and laparoscopic surgery, patient care, and resident/medical student education. Currently engaged in laparoscopic and ureteral healing research, as well as uses of fibrin glue in urology. White House Fellowship Office White House Fellow 712 Jackson Place, NW 1995 - 1996 Washington, DC 20503 Served as a special assistant to the Secretary of Transportation, Federico Pena. Responsible for writing speeches, drafting and reviewing proposed legislation answering Congressional inquiries, chairing meeting and conducting briefings. Participated with the Secretary and administration heads on matters pertaining to project plans and policies. Worked on health related issues in the Department of Transportation, both classified and unclassified. Department of Urologic Surgery Endourology Fellow Washington University School of Medicine 1990 - 1991 4960 Children's Place St. Louis, Missouri 63110 Served as the Extracorporeal Shockwave Lithotripsy (ESWL)/Endourology fellow. Responsibilities included patient care, surgery, medical student/resident teaching and research in laparoscopic surgical techniques. Department of Community Health Sciences Special Assistant to the Aga Khan University and Medical College Chairman P.O. Box 3500 Karachio-5, Pakistan 1985 - 1986 Assisted the departmental chairman in managing a complex agenda in a highly dynamic environment - facilitated administrative, academic, and external activities and relationships including developing proposals for external support. Participated in teaching, fieldwork, and direct patient care. Involved in developing primary health care programs for the squatter settlements in urban Karachi.
  16. 16. Mount Ascutney Hospital, Windsor, Vermont Emergency Room Northeast Rehab. Hospital, Salem New Hampshire Physician Brattleboro Hospital, Brattleboro, Vermont 1985 - 1991 Rockingham Hospital, Bellows Falls, Vermont Served as a physician in the emergency room. Responsibilities included direct patient care and providing emergency services to the hospital in-patients. Served as a coordinator of the emergency room physician at Mount Ascutney Hospital for four years and served as coordinator of physicians at Northeast Rehabilitation Hospital for five years. Rhode Island Hospital Laboratory Assistant Department of Pathology 1980 Providence, Rhode Island 02945 Assisted in various aspects of surgical and anatomical pathology. Duties included sectioning tissues for various microscopic examinations, photography, and autopsies. Rhode Island Department of Health Researcher Division of Epidemiology, Room 105 1979 (summer) Health Building Providence, Rhode Island 02908 Involved in a rubella research program involving college-aged women. Responsibilities included assessing the impact of a new Rhode Island state law, setting up immunization programs, and handling problems that developed. Brandt Associates, Inc. Laboratory Technician P.O. Box 81 1978 - 1979 Martins Creek, Pennsylvania 18063 Involved in various aspects of water and wastewater testing from the chemical and biological standpoints. Duties included designing a quality control system for the lab, data interpretation, computer work, and routine analyses. Lafayette College Laboratory Instructor Department of Geology 1976 - 1978 Easton, Pennsylvania 18042 Served as a laboratory instructor in an upper level geology course (mineralogy). Responsible for setting up demonstrations, giving lectures, and writing exams.
  17. 17. Appalachian Mountain Club Hutmaster/Hutboy Pinkham Notch Camp 1973 - 1976 Summers Gorham, New Hampshire 03581 Involved in operating a mountain hostel in the White Mountains. Duties included packing food supplies, cooking for up to ninety guests, developing mountain education programs and mountain rescue programs. The AMC is the oldest mountaineering/conservation organization in the country. I also worked at their main office in Boston, Massachusetts. AWARDS/DISTINCTIONS: Adolph A. Kutzman Visiting Professor (Cedars-Sinai Medical Center), Los Angeles, CA, November, 2002 Guest Professor, Chi Mei Medical Center, Tainan, Taiwan, May, 2002. Visiting Professor, University of Arkansas Medical Center, April , 2002. Visiting Professor, Medical University of South Carolina (Kenneth M. Lynch Memorial Visiting Professorship), Charleston, South Carolina, November, 2001. Visiting Professor, Singapore General Hospital, Singapore, September, 2001. Visiting Professor, Medical College of Wisconsin, June, 2001. Visiting Professor, Italian Urological Association, Sardenia, Italy, May, 2001. Visiting Professor, Pakistan Urological Association, Karachi, Pakistan, February, 2001. Selected as one of the “Top Doctors in the Chicago Area” as chosen by their peers. Chicago Magazine, January, 2001. Selected as one of the “Best Doctors in America” by peers. Castle Connolly Medical Ltd., Chicago, Illinois, January 2001. Visiting Professor, Icelandic Urological Association, Reykjavik, Iceland, October 2000. 2000 Pfizer/American Urological Association, Visiting Professorship in Urology, June, 2000. Selected as an Outstanding Physician in the Chicago Metropolitan Area: How to Find The Doctors: Chicago Metropolitan Area, Castle Connolly Medical Ltd, Chicago, IL, March, 2000. Visiting Professor, San Diego Naval Hospital, San Diego, California, July, 1999.
  18. 18. The Irving J. Shapiro Award - Dedicated to a physician who has performed outstanding service in the urogram conference of the Chicago Urological Society. April, 1999. Visiting Professor, University of Miami, Miami, Florida, March, 1999. Selected as one of the “Top Doctors in the Chicago Area” as chosen by their peers. Chicago Magazine, January, 1997. The Irving J. Shapiro Award - Dedicated to a physician who has performed outstanding service in the urogram conference of the Chicago Urological Society. April, 1997. Judge - The 29th Annual Washington Urological Society’s Resident Scholars Conference, Washington, D.C., February, 1996. White House Fellowship - Selected to spend a year in Washington, D.C. as a special assistant to Federico Pena. June, 1995. Alf H. Gunderson, M.D. Memorial Lecturer - Selected to deliver this memorial lecture at the Gunderson Clinic, LaCrosse, Wisconsin, September, 1995. The Irving J. Shapiro Award - Dedicated to a physician who has performed outstanding service in the urogram conference of the Chicago Urological Society. April, 1995. Visiting Professor, University, University of Florida, Gainesville Fl., March, 1995. Visiting Professor, Tulane University, New Orleans, LA, November, 1994. Visiting Professor, University of California, San Diego, CA, October, 1992. American College of Surgeons Cine-Clinic Award - Laparoscopic Adrenalectomy, October, 1994. Video Urology Award - Laparoscopic Adrenalectomy, August, 1994 Endourological Society Resident/Fellow Award - 2nd place: "Extracorporeal Shock Wave Lithotripsy (ESWL) for Ureteral Calculi: To Stint or Not to Stint." June, 1991. New Hampshire Chapter of the American College of Surgeons Best Trauma paper: "Urological Injury and Assessment in Patients with Pelvic Fractures." January, 1989. New Hampshire Chapter of the American College of Surgeons Best Trauma paper: "Bladder Rupture: A Review of 42 Cases." March, 1988. Awarded the Yoshioka Japan Hospital Association Fellowship (through the International Hospital Federation) to study primary health care programs in selected third world cities. US $4,000 March, 1986.
  19. 19. Medical Expedition to eastern Nepal with the Johns Hopkins University and the Woodlands Institute. Involved in a health survey of a village in eastern Nepal as well as in developing a field clinic. April, 1983. GRANTS: Photocure Grant. Principal Investigator: David M. Albala, M.D. Principal Investigator: David M. Albala, M.D.: A Randomized, Comparative, Post- Market Evaluation of Symptoms and Discomfort Associated with an Indwelling Ureteral Stent. Awarded $7,000 by Boston Scientific Corporation, Natick, Massachusetts, February, 2001. Principal Investigator: David M. Albala, M.D.: Flow Characteristics of the Lithostent. Awarded $20,000 by ACMI/Circon, Inc., Norwalk, Connecticut, January, 2001. Principal Investigator: David M. Albala, M.D. : Vaginal Thermotherapy for the Treatment of Urinary Incontinence. Awarded $30,000 by SURX, Pleasanton, California, September, 2000. Principal Investigator: David M. Albala, M.D.: Medstone STS-T Lithotriptor. Awarded $25,000 by Medstone, Inc., San Francisco, California, May, 2000. Principal Investigator: David M. Albala, M.D.: Nephro-Step : A New Device for Percutaneous Access. Awarded $5,000 by Innerdyne, San Francisco, California, March 2000. Principal Investigator: David M. Albala, M.D.: A New Laparoscopic Procedure for the Treatment of Urinary Incontinence. Awarded $50,000 by SURX, Pleasanton, California, April, 1999. Principal Investigator: David M. Albala, M.D.: A New Ureteral Stent. Awarded $10,000 by ACMI/Circon Inc., Norwalk, Connecticut, February, 1998 Principal Investigator: David M. Albala, M.D.: Thermotherapy Treatment for Benign Prostatic Hypertrophy. Awarded $75,000 by Thermatrix, Chicago, Illinois, January, 1997. Principal Investigator: David M. Albala, M.D.: Laparoscopic Ureteral Reanastomosis using Fibrin Glue. Awarded $15,000 by The National Kidney Foundation of Illinois. Chicago, Illinois, November, 1992. Principal Investigator: David M. Albala, M.D.: Contact Nd: YAG Laser Prostatectomy in the Canine Model. Awarded $12,000 by Surgical Laser Technology, Oaks, Pennsylvania. June, 1992.
  20. 20. Principal Investigator: David M. Albala, M.D., Co-Investigator: Mansel Kevwitch, M.D.; Laparoscopic Ureteral Reanastomosis Awarded $5,000 by Ethicon Endosurgical Institute, Cincinnati, Ohio. March, 1992. Principal Investigator: Department of Community Health Sciences, Aga Khan University and Medical College; The Aga Khan University Scholars in Community Health Sciences: A Career Development Program for Physicians and Nurses in Pakistan. Co-authored with Dr. John Bryant. Awarded C $1,110,000 by the Canadian International Development Agency, Canada, for a four-year project. November 1986. Principal Investigator: Department of Community Health Sciences, Aga Khan University and Medical College; A Proposal for a Primary Health Care Pilot Program in the Northern Areas of Pakistan. Co-authored with Dr. John Bryant, Dr. Eugene Boostrom, and Ms. Shameela Karmali. Awarded US $302,467 by the Aga Khan Foundation, Geneva and USAID, Washington, D. C. for a two-year project. July, 1986. Principal Investigator: Department of Community Health Sciences, Aga Khan University and Medical College; A Proposal for Studying Health and Health Services and for Developing Initiatives in Thatta District. Co-authored with Dr. John Bryant. Awarded C $253,416 by the International Development Research Center, Canada for a three-year study. September, 1986. Principal Investigator: Department of Community Health Sciences, Aga Khan University and Medical College; The Sequential Development of Primary Health Care Modules in Katchi Abadies and Other Low Income Settlements of Urban Karachi. Co-authored with Dr. John Bryant. Awarded US $503,147 by the Aga Khan Foundation, Geneva, for a three-year study. February, 1986. RESEARCH PROJECTS: Principal Investigator: David M. Albala, M.D., Lower Pole II: A Prospective Randomized Trial of Ureteroscopy and Percutaneous Nephrostolithotomy for Lower Pole Nephrolitiasis. Study conducted at Loyola University Medical Center and Duke University Medical Center, 2000-present. Principal Investigator: David M. Albala, M.D., Flow Characteristics of the Lithostent. Study conducted at Loyola University Medical Center 2000 - 2001. Principal Investigator: David M. Albala, M.D., A Randomized, Comparative, Post- Market Evaluation of Symptoms and Discomfort Associated with an Indwelling Ureteral Stent. Study conducted at Loyola University Medical Center and other academic medical centers, 2000 - 2001.
  21. 21. Principal Investigator: David M. Albala, M.D., Medstone STS-T: A Multi-institutional Study. Study conducted at Loyola University Medical Center and other academic medical centers, 2000 - 2001. Principal Investigator: David M. Albala, M.D., Vaginal Thermotherapy for the Treatment of Urinary Incontinence. Study conducted at Loyola University Medical Center, 2000 - 2001. Principal Investigator: David M. Albala, M.D., Thermotherapy Treatment for Benign Prostatic Hypertrophy (Multi-Institutional Randomized Study). Study conducted at Loyola University Medical Center and other academic medical centers, 1998 - 2000. Principal Investigator: David M. Albala, M.D., Optimal Therapy for Middle and Distal Calculi (Multi-Institutional Randomized Study) Study conducted at LUMC and other academic medical centers, 1995 - 2000. Principal Investigator: David M. Albala, M.D., Lower Pole I: A Prospective Randomized Trial of Extracorporeal Shock Wave Lithotripsy and Percutaneous Nephrostolithotomy for Lower Pole Nephrolithiasis. Study conducted at Loyola University Medical Center and other academic medical centers, 1997 – 2000. Principal Investigator: David M. Albala, M.D., A New Laparoscopic Procedure for the Treatment of Urinary Incontinence. Study conducted at Loyola University Medical Center and other academic medical centers, 1999 - 2000. Principal Investigator: David M. Albala, M.D., Evaluation of a New Model Ureteral Stent. Study conducted at Loyola University Medical Center. 1999 - 2000. Principal Investigator: David M. Albala, M.D., Direx Tripter X1 Lithotripter: Fragmentation of Upper Urinary Stones. (FDA Trial - Project # 0051) Study conducted at LUMC, 1992-1996. Principal Investigator: David M. Albala, M.D., Leonard Gomella, M.D. and Douglas Milam, M.D.: Contact Nd: YAG Laser Prostatectomy in the Canine Model. (Surgical Laser Technology, Inc. Study #B243-0). Study conducted at LUMC, 1992-1993. Principal Investigator: David M. Albala, M.D. Fluoroscopically Controlled Incision of Upper Urinary Tract Strictures. (Applied Urology, Inc Study #C91-002) Study conducted at LUMC, 1991-1993. Principal Investigator: Stuart M. Selikowitz, M.D. Co-Investigator: David M. Albala, M.D. Informed Patient Decision-Making in Patients with BPH: Pilot Project. A pilot benign prostate hypertrophy informed patient decision-making program (IPDP) conducted at the Veterans Administration Hospital, White River Junction, VT, in conjunction with the Dartmouth Medical School Department of Community Medicine, 1989 - 1991.
  22. 22. Principal Investigator: John A. Heaney, M.D. Co-Investigator: David M. Albala, M.D. Phase III - Patient preference and quality of life in metastatic prostate carcinoma: Zoladex versus orchiectomy. (Stuart Pharmaceuticals ZOL - 7-624-3) - Study conducted at Dartmouth-Hitchcock Medical Center, 1987 - 1990. Principal Investigator: John A. Heaney, M.D. Co-Investigator: David M. Albala, M.D. Phase III - Long-term efficacy and safety of Terazosin in the treatment of the symptoms of benign prostatic hypertrophy. (Abbott Laboratory Protocol Number M87-006) - Study conducted at Dartmouth-Hitchcock Medical Center, 1987 - 1990. JOURNALS: EDITORIAL BOARD: Journal of Endourology – Editorial Board 2001 - present Urology Index & Reviews - Editor 1997 – present Current Opinion in Urology-Editorial Board 2001- present Techniques in Urology - Editor in Chief* 1994 – 2002 *Techniques in Urology was accepted in Medline in 1996, two years after its inception. JOURNALS: REVIEWER/ABSTRACTOR Urology 1994 - present Obstetrics and Gynecology 1994 - present Journal of Urology 1992- present Journal of Endourology 1990 - present Surgery, Gynecology, and Obstetrics 1990 – present British Journal of Urology 2000-present COURSES: PROGRAM DIRECTOR Hand Assisted Laparoscopic Urological Surgery—Duke University Medical Center, March 2002; April 2002; May 2002; June 2002; August 2002; September 2002; October 2002; November 2002; December 2002; January 2003; April 2003.
  23. 23. Urological Laparoscopy-American College of Surgeons Clinical Congress, October, 2001. Hand Assisted Laparoscopic Urological Surgery - Loyola University Medical Center, August, 2000; September, 2000; October, 2000; December 2000; January 2001; March, 2001; April, 2001; September, 2001. Management Strategies for the Treatment of UPJ Obstruction - American Urological Association, June, 1998; June 1999. New Horizons in Urology - Loyola University Medical Center; February, 1992; October, 1992; May, 1993. FACULTY Laparoscopic Urological Surgery—American Urological Association Annual Review Course (Chicago), March 2002; May 2003. Annual International Course on Urological Laparoscopic Surgery, Medical University of Ribeirao Preto, Brazil, July 2001; September, 2001. Hand-Assisted Laparoscopy- American Urological Association; February, 2001. Hand- Assisted Laparoscopic Urological Surgery - Ethicon Endosurgical Institute; November, 2000; May, 2001; October 2001; March 2002. Laparoscopic Urology - Brazilian Urological Association; November, 2000. Frontiers in Endourology - Washington University School of Medicine; June, 1991; June, 1992; July, 1994. Lasers and Laparoscopy in Urology - New Jersey Laser Institute; September, 1991. Laparoscopic Surgery - University of Minnesota Medical Center; October, 1991. Minimally Invasive Surgery - Thomas Jefferson Medical School; May, 1992; July, 1992; August 1995. Laparoscopic Surgery - Harvard Medical School; April, 1992. Laparoscopic Urology - Tulane University Medical School; November, 1991; February, 1992; May, 1992, March, 1993, September 1993, November 1994. Laparoscopy in Urology - New York University Medical School; December, 1991; March, 1992; June, 1992; December, 1992; May 1993, July 1994.
  24. 24. Laparoscopic Urology - Cornell University Medical Center; February, 1992; May, 1992; September, 1992, March, 1993; October, 1993; May, 1994. Laparoscopic Urology - Georgetown University Medical School; March, 1992. Laparoscopic Urology - Dartmouth-Hitchcock Medical Center; January, 1992. Laparoscopy - American Urological Association- October, 1992; May 1993, May 1994, January, 1995, May, 1995. Advanced Laparoscopy - American Urological Association; March, 1993. Lasers in Urology - Cornell University Medical Center, February, 1994; April, 1994. PUBLICATIONS: ARTICLES: Dahm, P., Paulson, D., and Albala, D.M.: Management of Retained Retractor During Radical Perineal Prostatectomy. Journal of Urology 159:1085, 2003. Albala, D.M., Turk, M.T., Fulmer, B.R., et al: Office -Based Transurethral Microwave Thermotherapy (TUMT) using the Thermatrix TMX-2000. Journal of Endourology 16:57, 2002. Fulmer, B., Sakamoto, K., Albala, D.M., et al.: Acute and Long-Term Outcome of Radiofrequency Bladder Neck Suspension. Journal of Urology 167:141, 2002. Fulmer, B.R., Turk, M.T. and Albala, D.M. : Editorial: Retroperitoneoscopic Adrenalectomy: Lateral Approach. Journal of Endourology 15:505, 2001. Sadowski, E.A., Salomon, C.G, Wojcik, E.M. and Albala, D.M.: Fibroma of the Testicular Tunics: An Unusual Extratesticular Intrascrotal Mass. Journal of Ultrasound Medicine 20:1245, 2001. Kumar, U. and Albala, D.M.: Laparoscopic Approach to Adrenal Carcinoma. Journal of Endourology 15: 339,2001. Albala, D.M., Assimos, D.G., Clayman, R.V. et al: Lower Pole I: A Prospective Randomized Trial of Extracorporeal Shockwave Lithotripsy and Percutaneous Nephrostolithotomy for Lower Pole Nephrolithiasis—Initial Results. Journal of Urology 166:2072, 2001. Kumar, U., Dickerson, A., Sakamoto, K., Albala, D.M., and Turk, T.M.T. : Effects of Fibrin Glue on Injured Rabbit Ureter. Journal of Endourology: 15: 205, 2001.
  25. 25. Kumar, U. and Albala, D.M.: Techniques in Intracorporeal Tissue Approximately: Suturing, Newer Tissue Adhesives and Microclips. Urologic Clinics of North America 28:15, 2001 Galen, D.I., Abbott, K., Albala, D.M. et al: Radiofrequency Bladder Neck Suspension: Long Term Results Using a Laparoscopic Approach. Obstetrics and Gynecology 97:49, 2001. Kumar, U. and Albala, D.M.: Fibrin Glue Applications in Urology. Current Urology Review, 2:79, 2001. Albala, D.M., Turk, M.T., Fulmer, B.R., et al: Periurethral Transurethral Microwave Thermotherapy (P-TUMT) for the Treatment of BPH: An Interim 1 year Safety and Efficacy Analysis Using the Thermatrix TMX - 2000. Techniques in Urology 6:288, 2000. Kumar, U. and Albala, D.M.: Simple Nephrectomy: Transperitoneal Approach. Journal of Endourology 14:10, 2000. Wolf, J.S., Marcovich, R., Albala, D.M. et al: Survey of Neuromuscular Injuries to the Patient and Surgeon During Urologic Laparoscopic Surgery. Urology 55:831, 2000. Albala, D.M., Rassweiler, J., Winfield, H.N. et al: Controversial Cases in Endourology. , Rassweiler, J., Winfield, H.N. et al: Controversial Cases in Endourology. Journal of Endourology 14:541, 200. Fulmer, B.R., Turk, M.T. and Albala, D.M.: Complications of Retrograde Balloon Cautery Endopyelotomy Journal of Urology 165: 542, 2000 Turk, T.M.T., Koleski, F., Wojcik, E., Jahoda, A., and Albala, D.M.: Use of Epidermal Growth Factor and Collegen Synthesis Inhibition As Adjuvant to Healing of Ureteral Anastomosis. Journal of Endourology 14:145, 2000. Koleski, F., Turk, T.M.T., Jahoda, A., and Albala,D.M.: Grooved Ureteral Stent: Preliminary Evaluation. Journal of Endourology 14:2, 2000. Koleski, F., Turk, T.M.T., and Albala, D.M.: Laparoscopic Adrenalectomy. AUA News 4:3, 1999. Koleski, F., Turk, T.M.T., Orwega, M., Borge, M., and Albala D.M.: Splenosis as a cause for Testicular pain - Laparoscopic Management. Journal of Endourology 13:373, 1999. Koleski, F., Turk, T.M.T, and Albala, D.M.: Update on Endourology and Laparoscopic Urology. Chicago Medicine 102:17, 1999.
  26. 26. Koleski, F., Turk, T.M.T., and Albala D.M.: Carcinosarcoma of the Prostate. World Journal of Urology 17:316, 1999 Albala, D.M.: Review of Campbells Urology, Doody’s Review 3:26, 1999 Turk,T.M.T., Koleski, F.C., and Albala D.M.: Incidence of Urolithasis in Cystectomy Patients after Intestinal Conduit or Continent Urinary Diversion. World Journal of Urology 17:305,1999 Jahoda, A.E., Albala, D.M., Dries, D.J., and Kovacs E.J.: Fibrin Sealant Inhibits Connective Tissue Deposition in a Murine Model of Peritoneal Adhesions. Surgery 125:53, 1999. Herrell, S.D., Jahoda, A.E., Husain, A.N., and Albala, D.M.: The Laparoscopic Cooling Sheath: A Novel Device for Hypothermic Preservation of the Kidney During Temporary Renal Artery Occlusion. Journal of Endourology 12:155, 1998. Gill, I.S., Clayman, R.V., and Albala D.M. et.al: Retroperitoneal and Pelvic Extraperitoneal Laparoscopy: An International Perspective, Urology 52:566, 1998 Kim, F.J., Herrell, S.D., Jahoda, A.E., Albala, D.M.: Complications of Acucise Endopyelotomy. Journal of Endourology 12:433, 1998. Gomella, C., Loft, M., Hirsch, I., Albala, D.M., Manyak, M., Sosa, E., and Stone, N.: Laparoscopic Urologic Surgery: Outcome Assessment. Journal of Laparoscopic and Advanced Surgical Techniques 7:77, 1997. Preminger, G.M., Clayman, R.V., Nakada, S.Y., Babayan, R.K., Albala, D.M., Fuchs, G.J., Smith, A.D. A multicenter clinical trial investigating the use of a fluoroscopically controlled cutting balloon catheter for the management of ureteral and ureteropelvic junction obstruction. Journal of Urology 157:1625, 1997. Gomella, L.G., Abdel-Meguid, T.A., Lofti, M.A., Hirsch, I.H., Albala, D.M., Manyak, M., Kozminski, M., Sosa, E., Stone, N.N. Laparoscopic Urologic Outcome Assessment. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A. 7:77, 1997. Albala, D.M.: Contact Laser Vaporization of the Prostate for Benign Prostatic Hypertrophy. Monographs in Urology 8:92, 1997 Gerber, G., Jahoda, A., Bales, G., and Albala, D.M.: Transurethral Vaporization of the Prostate in the Treatment of Bladder Outlet Obstruction at Two University Hospitals. Techniques in Urology 3:25, 1997. Ferrer, F., MacGillivray, D., Malchoff, C., Albala, D.M., and Schickman, S.J.: Bilateral Laparoscopic Adrenalectomy for Adrenocorticotropic-Dependent Cushing’s Syndrome. Journal of Urology 157:16, 1997.
  27. 27. Mendoza, D., Neuman, R., Albala, D.M., Cohen, M., et al: Laparoscopic Complications in Markedly Obese Urologic Patients (A Multi-Institutional Review). Urology 48:562, 1996. Brown, J., Albala, D.M., and Jahoda, A.: Laparoscopic Surgery for Advanced Lesions. Seminars in Surgical Oncology 12:96, 1996. Albala, D.M., Brown, J., and Jahoda, A.J.: Laparoscopic Adrenalectomy. Seminars in Surgical Oncology 14:216, 1996. Seilkowitz S. and Albala, D.M.: A Method of Exposing the Vesicourethral Anastomotic Site During Radical Prostatectomy. Journal of Urology. 154:1461, 1995. Albala D.M., Jahoda, A.E., McKay, T.C., and Castelli, M.: Ureteral Reanastomosis Using Fibrin Glue. Journal of Pelvic Surgery 1:49,1995. Albala DM., Galal HA., and Gomella LA: Laparoscopic Pelvic Lymph Node Dissection for Prostate Cancer. Atlas of the Urologic Clinics of North America, 3:43, 1995. Kerbl, K., Clayman, R., McDougall, E.M., Gill, I.S., Wilson B.S., Chandhoke, P.S., Albala, D.M., Kavoussi, L.R.: Transperitoneal Nephrectomy For Benign Disease Of The Kidney: A Comparison of Laparoscopic And Open Surgical Techniques. Urology 43: 607,1994. Anderson, K., Keetch, D., Albala, D.M., Chandhoke, P., McClennan, B. and Clayman, R.V.: Optimal Therapy for the Distal Ureteral Stone: Lithotripsy vs. Ureteroscopy. Journal of Urology . 152:62, 1994. Gomella, L.G., Lotfi, M.A., Milam. V., Albala, D.M., and Reagan G: Contact Laser Vaporization Of The Prostate For Benign Prostatic hypertrophy. Progress in Biomedical Optics, 2129:73, 1994. Albala, D.M.: Laparoscopic Nephrectomy and Adrenalectomy. Seminars in Surgical Oncology 10:417, 1994. Gomella L.G., and Albala, D.M.: Laparoscopic Urology Surgery 1994. British Journal of Urology 74:267, 1994. Albala, D.M., Prien, E.L. and Galal, H.A.: Urolithiasis as a Hazard of Sulfonamide Therapy. Journal of Endourology 8:401, 1994. Albala, D.M., Richardson, J.R., and Heaney, J.A.: Diuretic Renal Scan: Is It Always Reliable. Journal of Endourology. 8:405, 1994.
  28. 28. Monk, T.G., Albala, D.M., Diaz, Y., Clayman, R.V., and White, C.F., Topical EMLA Analgesia: Effects on Pain Response and Analgesic Requirement During Lithotripsy Procedures. Anesthesia and Analgesia. 79:506, 1994. McKay, T.C., Albala, D.M. and Gehrin, B.: Laparoscopic Ureteral Reanastomosis Using Fibrin Glue. Journal of Urology 152:1637, 1994. McKay, T.M., Albala, D.M., Sendelbah, K. and Gattuso, P.: Cytomegalovirus Prostatitis: Case Report and Review of the Literature. International Urology and Nephrology. 26:535, 1994. Albala, D.M.: How to Approach the Problematic Ureteral Stone. Contemporary Urology 5:64,1993. Klutke, J. Kavoussi, L.R., Albala, D.M., and Clayman, R.V., Laparoscopic Treatment of Ureteral Obstruction Secondary to Ovarian Remnant Syndrome, Journal of Urology. 149:827, 1993. Kerbl, K., Figenshau, R., Clayman, R., Chandhoke, P., Kavoussi, L., Albala, D.M. and Stone, A.: Retroperitoneal Laparoscopic Nephrectomy: Laboratory and Clinical Experience. Journal of Endourology 7:23, 1993. Klutke, J., Kavoussi, L., Albala, D.M., Clayman, R.: Laparoscopic Treatment of Ureteral Obstruction Secondary to Ovarian Remnant Syndrome. Journal of Urology 149:827, 1993. Albala, D.M., Kevwitch, M.K. and Waters, W.B.: Treatment of Persistent Lymphatic Drainage after Laparoscopic Pelvic Lymph Node Dissection and Radical Retropubic Prostatectomy. Journal of Endourology 7:337, 1993. Kavoussi, L.R., Albala, D.M., and Clayman, R.V.: Outcome of Secondary Ureteropelvic Junction Obstruction Failures. British Journal of Urology 72:157, 1993. Gagner, M., Lacroix A., Prinz R., Bolter E., Albala, D.M. Potvin, C., and Hamet, P: Early Experience with Laparoscopic Approach for Adrenalectomy. Surgery 114:1120, 1993. Albala, D.M., Schuessler, W.W., and Vancaille, T.G.: Laparoscopic Bladder Neck Suspension. Journal of Endourology, 6:137, 1992. Clayman, R.V., Kavoussi, L.R., Soper, N.J., Albala, D.M., Figenshau, R.S., and Chandhoke, P.S. Laparoscopic Nephrectomy: Review of the Initial 10 Cases. Journal of Endourology 6:127, 1992. Chandhoke, P.S., Albala, D.M. and Clayman, R.V.: Long Term Comparison and Renal Function in Patients with Solitary and/or Renal Insufficiency Undergoing ESWL or Percutaneous Nephrolithotomy, Journal of Urology. 147:1226, 1992.
  29. 29. Clayman, R.V., Kavoussi, L.R., McDougall, E.M., Soper, N.J., Figenshau, R.S., Chandhoke, P.S. and Albala, D.M.: Laparoscopic Nephrectomy: A Review of 16 Cases. Surg. Laparoscopy and Endoscopy 2:29, 1992. Albala, D.M., Kavoussi, L.R., and Clayman, R.V: Laparoscopic Nephrectomy. Seminars in Urology, 10:146, 1992. Kavoussi, L.R., Albala, D.M., Basler, J.W., Apte, S. and Clayman, R.V.: Percutaneous Management of Urolithiasis During Pregnancy. Journal of Urology. 148:1069, 1992. Albala, D.M. Schuessler W.W., and Vancaillie, T.G.: Laparoscopic Bladder Suspension For The Treatment Of Stress Incontinence. Seminars in Urology 10:222, 1992. Meretyk S., Albala, D.M., Clayman R.V., Denstedt, J. and Kavoussi, L.R: Endoureterotomy For The Treatment Of Ureteral Strictures. Journal of Urology 147:1502, 1992. Albala, D.M.: Clayman, R.V.: Commentary: Percutaneous Nephrolithotomy An Approach to Branded and Staghorn Renal Calculi. Journal of Lithotripsy and Stone Disease, 3:182, 1991. Albala, D.M. and Richardson, J.R., Jr: Diagnosis and Treatment of Bladder Rupture: A Review of 42 Cases. Rhode Island Medical Journal, 74:133, 1991. Albala, D.M., Richardson, J.R., and Heaney, J.A.: Urological Injury and Assessment in Patients with Pelvic Fractures. Rhode Island Medical Journal, 74:128, 1991. Huntsman, W.T., and Albala, D.M.: Cardiac Tamponade as an Unusual Presentation of Lung Cancer: A Case Report and Review of the Literature. Clinical Cardiology, 14:529, 1991. Figenshau, R.S., Albala, D.M., Clayman, R.V., Kavoussi, L.R., Chandhoke, P.S., and Stone, A.M.: Laparoscopic Nephroureterectomy: Initial laboratory Experience, Minimally Invasive Therapy, 1:93, 1991. Albala, D.M., Meretyk, S. and Clayman, R.V.: Extracorporeal Shock Wave Lithotripsy (ESWL) for Ureteral Calculi: To Stint or Not to Stint, Journal of Endourology, 5:277, 1991. Albala, D.M., Chung, C.J., Sueoka, B.L., Memoli, V.A., and Heaney, J.A.: Hemorrhagic Myelolipoma of the Adrenal Gland After Blunt Trauma. Urology, 38:559, 1991. Clayman, R.V., Kavoussi,, L.R., Figenshau, R.S., Chandhoke, P.S., and Albala, D.M.: Laparoscopic Nephroureterectomy: Initial Clinical Case Report. Journal of Laparoendoscopic Surgery, 1:343, 1991.
  30. 30. Albala, D.M., Danaher, J., and Huntsman, W.T.: Ventriculoperitoneal Shunt Migration Into the Scrotum. The American Surgeon, 55:685, 1989. Albala, D.M. and Danaher, J.W.: Thank you, Sahib. Dartmouth Medical School Alumni Magazine, Winter 1987. Albala, D.M.: Primary Health Care in Bangkok. World Hospitals, 23:1, 1987. Albala, D.M., Faisel, A., Fikree, F. and Bryant, J.: The Educational Programs of the Aga Khan University Department of Community Health Sciences. Specialist, 2:25, 1986. Albala, D.M., Quershi, F.A. and Karim, M.S.: A Comparison of Health and Socioeconomic Indicators in the Townships of Orangi and Karimabad. Journal of Pakistan Medical Association, 36:9, 1986 Albala, D.M.: Healing the Sick in Pakistan, Special two-part article in The Valley News, West Lebanon, NH October 1986. Albala, D.M., Huntsman, W.T. and Crichlow, R.W.: Gallstone Ileus. Surgical Rounds, 8:93, 1985. Albala, D.M., and Taylor-Ide, D.: Water Quality and Diarrheal Diseases in a Rural Community of Eastern Nepal. Journal of the Institute of Medicine, 7:13, 1985. Albala, D.M., Bromley, B., Culver, J., et al: Medical Report from Isolated Communities in Sankhuwsabha District - Kosi Zone. Journal of the Institute of Medicine, 7:21, 1985. Albala, D.M.: The Spirit of Nepal. Lafayette College Alumni Magazine, Summer, 1985 Albala, D.M. and Schamel, S.: Water Quality of the Martins Creek Drainage Basin. Proceedings of the Pennsylvania Academy of Sciences, 53:101, 1979. SUBMITTED: Fulmer, B., Turk, T., Albala, D.M., et al.: Extracorporeal Shock Wave Lithotripsy with the Medstone STS-T (Transportable) Electrohydraulic Lithotripter: Experience with 370 Cases. Journal of Endourology. Albala, D.M., Del Guidice, P., Coombs, D.W., and Colburn, R.: Temporal Correlation Between Toxic Plasma and Urinary Inorganic Fluoride Levels and Urinary PGE2 in the Ewe. Canadian Journal of Anesthesia. Toselli, C.V., Fleming, C., Albala, D.M., and Selikowitz, S.M.: A Decision Analytic Approach to the Management of Clinical Stage I Non-Seminomatous Germ Cell Testicular Tumors. Techniques in Urology.
  31. 31. Griffin, J., Hatch, D. and Albala, D.M.: Laparoscopic Replacement of CAPD Catheters. Journal of Urology. Jahoda, J., Simon, S., Albala, D.M., et al.: Systemic Effects of Intraparenchymal Injection of Fibrin Sealant for Renal Lacerations. Journal of Urology. BOOKS (Editors) Atlas of Endourology Albala, D.M., and Grasso, M.,: (Eds.) Raven Press, New York, NY, 1999. Textbook of Endourology, Albala, D.M., Sosa, E.R., Perlmutter, A.B. and Jenkins, A., (Eds.), W. B. Saunders, Cambridge, Mass., 1996. BOOKS (Assistant Editor) Five Minute Urological Consult, Gomella, L.G. (Ed), Lippencott-Raven Press, New York, N.Y.,2000. Laparoscopic Urologic Surgery, Gomella, L.G., Kozminski, M., Winfield, H.N., (Eds.), Raven Press, New York, NY, 1993. BOOK CHAPTERS/MONOGRAPHS: Albala, D.M.: Laparoscopic Hand-Assisted Nephrectomy. Hemal, A.K. (Ed). Contemporary Trends in Laparoscopic Urologic Surgery, B.I. Churchill Livingston, New Delhi, 2002. Kumar, U. and Albala, D.M.: Fibrin Sealants in Urology. Minimally Invasive Therapies in Urology, Marcel Decker, New York, 2001. Martins, A.C. and Albala, D.M.: Prostate and Hormones. Martins, A.C. (Ed) Benign Prostate Diseases, FAEPA – Hospital das Clinicas de Ribeirao Preto, Ribeiro Preto, Brazil, 2001. Koleski, F.C. and Albala, D.M.: Acute Urinary Retention. Mulhall, J.P. (Ed). Contemporary Diagnosis and Management of Urologic Emergencies, Handbooks in Health Care Co., Newtown, Pennsylvania, 2001. Koleski, F.C. and Albala, D.M.: Laparoscopia Equipamento Castilho, L.C. (Ed). Laparoscopia Urologica. LPC Comunicacoes, Sao Paulo, Brazil, 2000. Koleski, F.C. and Albala, D.M.: Cirurgia do Ureter. Castilho, L.C. (Ed). Laparoscopia Urologica, LPC Comunicacoes, Sao Paulo, Brazil, 2000.
  32. 32. Kumar, U. and Albala, D.M.: Radionucleotide Imaging. Levine, D. (Ed) Urology Pearls of Wisdom Boston Medical Publishing, Boston, Mass., 2000. Kumar, U. and Albala, D.M.: Urinary Tract Infections. Levine, D. (Ed) Urology Pearls of Wisdom Boston Medical Publishing, Boston, Mass., 2000. Kumar, U. and Albala, D.M.: Urinary Tract Obstruction. Levine, D. (Ed) Urology Pearls of Wisdom Boston Medical Publishing, Boston, Mass., 2000. Albala, D.M., and Koleski, F.: Nephrolithiasis. Gomella, L.G. (Ed). Five Minute Urology Consult, Raven-Lippencott Press, New York, N.Y., 2000. Albala, D.M.: Backpacking to the Capital. McCrea Curnen, M., Spiro, H., and St. James, D. (Eds) Doctors Afield Yale University Press, New Haven, Ct., 1999. Kumar, U. and Albala, D.M.: History of Laparoscopy and Laparoscopic Instrumentation. Hemal, A.K. (Ed). Laparoscopic Surgery in Urology, B.I. Churchill Livingstone, New Delhi, India, 1999 Kumar, U. and Albala, D.M.: Hand Assisted Laparoscopic Surgery in Oncology. Hemal, A.K. (Ed). Laparoscopic Surgery in Urology, B.I. Churchill Livingstone, New Delhi, India, 1999 Albala, D.M.: Laparoscopic Adrenalectomy. In Glenn, J (Ed). Urologic Surgery, J.B. Lippincott, Philadelphia, PA, 1998. Albala, D.M.: Laparoscopic Adrenalectomy. In Albala, D.M., Sosa, E.R., Perlmutter, A.B and Jenkins, A., (Eds) Textbook of Endourology. W.B. Saunders, Cambridge, Mass, 1996. Albala, D.M., and Isacksen, R.: Laparoscopic Bladder Neck Suspension. In Albala, D.M., Sosa ER, Perlmutter, AB., and Jenkins A., (Eds). Textbook of Endourology. W.B. Saunders, Cambridge, Mass, 1996. Albala, D.M., and Brown JP: Endopyelotomy For The Treatment Of Ureteropelvic Junction Obstruction. In Rous, S.N. (Ed) 1995 Urology Annual East Norwalk, CT Appleton & Lange 1995. Albala, D.M.: Laparoscopic Adrenalectomy, In Smith, A.J. (Ed) Smith=s Endourology Textbook, St. Louis, Quality Medical Publish, Inc. 1995. Isacksen, R., Albala, J.C., Jahoda A.E., and Albala, D.M.: Legal Issues in Laparoscopy In Smith, A.J., (Ed) Smith=s Endourology Textbook. St. Louis, Quality Medical Publish, Inc. 1995.
  33. 33. Albala, D.M., Chandhoke, P.S., and Clayman, R.V.: Ureterorenoscopy: Urolithiasis. In Krane, R., Siroky, M., and Fitzpatrick, J. (Eds.) Clinical Urology. Philadelphia, PA: J.B. Lippincott Company, 1994. Albala, D.M.: Postoperative Laparoscopic Care. In Soper, N., Oden, R., Clayman, R. and McDougal, E. (Eds.) Essentials of Laparoscopy St. Louis: Quality Medical Publishing, Inc., 1994. Albala, D.M.: Laparoscopic Nephrectomy. In Steichen F.M., Welter R, (Eds.) Minimally Invasive Surgery and New Technology. St Louis: Quality Medical Publishing, Inc., 1994. Albala, D.M.: Vesicoureteral Reflux in Adults. In Seidmon, J., Hanno, P. and Kaufman, J. (Eds.), Current Urologic Therapy, W.B. Saunders Company, Cambridge, Mass., 1993. Albala, D.M.: Laparoscopic Surgery in Urology. In Roig, JMS (Eds.) Progress in Urology 1993. Barcelona, Spain: Support Med Publishing, 1993. Albala, D.M. and Prinz, R.: Retroperitoneal Evaluation and Resection of Adrenal Masses. In Rosin, D. and Greene, F. (Eds.) Minimal Access Surgical Oncology. Radcliffe Medical Press, New York, NY, 1993 Albala, D.M.: Preparing for an International Meeting. In St. James, D. (Ed.), Writing and Speaking for Excellence: A Practical Guide for Physicians, Jones and Bartlett, Boston, Mass., 1993. Albala, D.M.: Stenting Prior to ESWL - Complications. In Smith, A.D. (Ed.) Controversies in Endourology, W.B. Saunders Company, Cambridge, Mass., 1993. Albala, D.M. and Kavoussi, L.R.: Laparoscopic Ureteral Surgery. In Das, S. and Crawford, D., (Ed.) Laparoscopic Urology, Orlando, FL, W. B. Saunders Company, 1993. Albala, D.M., Vancaille, T.G., and Schuessler, W.W.: Suspension of the Bladder Neck Using the Laparoscope. In Gomella, L., Kozminski, M. and Winfield, H. (Eds.) Laparoscopic Urologic Surgery, New York, N.Y., Raven Press, 1993. Albala, D.M.: Postoperative Laparoscopic Care. In Clayman, R. and McDougall, E., (Eds.) Laparoscopic Urology, St. Louis, MO, Quality Medical Publishers, 1992. Meretyk, S., Albala, D.M., Kavoussi, L., and Clayman, R.V.: Endosurgery: Non- Calculus Applications in the Upper Urinary Tract. In Stamey, T.A. (Ed.) Monographs in Urology. Montverde, FL: Medical Directions Publishing Company, 1991, Volume 12, No. 4.
  34. 34. Albala, D.M., Prien, E.L., Jr., and Heaney, J.A.: Drug-Induced Urinary Lithiasis. In Rous, S.N. (Ed.) 1990 Urology Annual. East Norwalk, CT., Appleton & Lange, 1990, pp. 255-266. VIDEOTAPES: Fulmer, B.R., Turk, T.M.T. and Albala, D.M.: Nephro-Step for Percutaneous Access (10 minutes), 2001 Albala, D.M.: Urological Laparoscopy: Hand-Assisted Nephrectomy, Adrenalectomy and Radical Prostatectomy. (15 minutes), 2001. Fulmer, B.R., Turk, T.M.T. and Albala, D.M.: Hand - Assisted Nephrectomy using the Intromitt. (10 minutes), 2000. Albala, D.M., Turk, T.M.T. and Fulmer, B.R.: Nephro-Step: A New Device for Percutaneous Access. (8 minutes), 2000. Kumar, U., Dickerson, A. and Albala, D.M.: Transurethral Resection of the Prostate using the Marberger Loop. (8 minutes), 2000. Albala, D.M., Turk, T.M.T., and Koleski, F.: Percutaneous Nephrolithotomy: Our Surgical Technique (10 minutes), 1999. Albala, D.M., and Thomas, R.: Laparoscopic Adrenalectomy: A Step-by-Step Approach (12 minutes), 1997. Herrell, D., Jahoda, A., and Albala, D.M.: The Use of Fibrin Glue in Urology (14 minutes), 1996. Albala, D.M. and Jahoda A.J.: Electrosurgical Vaporization of the Prostate - A New Procedure (10 minutes), 1995. Albala, DM and Flanigan, RF: Laparoscopic Adrenalectomy. American College of Cine Clinics (14 minutes), 1994. Isacksen, RM, Jordan G, Albala, DM, and Winslow, B: Laparoscopy in Children (10 minutes), 1994 Albala, D.M. and Prinz, R.: Laparoscopic Adrenalectomy, Video Journal of General Surgery, Volume 2, No. 1, (12 minutes), 1993. Asbury, J.A. and Albala, D.M.: Laparoscopic Renal Cyst Surgery (9 minutes), 1993. Isacksen, R.M. and Albala, D.M.: The Role of Laparoscopy in Undescended Testes. (8 minutes), 1993.
  35. 35. McKay, T. and Albala, D.M.: Laparoscopic Ureteral Reanastomosis Using Fibrin Glue (9 minutes), 1993. Albala, D.M. and Prinz, R.: Laparoscopic Adrenalectomy for Cushings Disease (10 minutes), 1993. Albala, D.M. and Prinz, R.: Laparoscopic Adrenalectomy (8 minutes), 1992. Kinzler, G.J. and Albala, D.M.: Laparoscopic Drainage of the Post Transplant Lymphocele (10 minutes), 1992. Albala, D.M. and Kinzler, G.J.: Laparoscopic Placement of a Difficult Continuous Ambulatory Peritoneal Dialysis (CAPD) Catheter (9 minutes), 1992. Albala, D.M., Kevwitch, M.K. and Gehrin, B.: Acucise Endopyelotomy - A New Surgical Procedure (9 minutes), 1992. Kavoussi, L.R., Clayman, R.V., Figenshau, R.S., Soper, N.J., Chandhoke, P.S. and Albala, D.M.: Laparoscopic Nephrectomy: Initial Clinical Experience with a New Surgical Technique, (10 minutes), 1992. Kavoussi, L.R., Albala, D.M, and Clayman, R.V., Laparoscopic Ureterolysis, (10 minutes), 1992. Albala, D. M., Figenshau, R.S., Chandhoke, P.S., Kavoussi, L.V., and Clayman, R.V.: Potential Complications of Laparoscopic Surgery, (10 minutes), 1991. Kavoussi, L.V., Albala, D.M., and Clayman, R.V.: Laparoscopic Ureterolysis, A New Surgical Approach (8 minutes), 1991. Kavoussi, L.V., Albala, D.M., and Figenshau, R.S., and Clayman, R.V., Organ Entrapment Systems for Tissue Removal, (9 minutes), 1991. Chandhoke, P.S., Clayman, R.V., Albala, D.M., Figenshau, R.S. and Kavoussi, L.R.: Acucise Endopyelotomy: Initial Clinical Experience (10 minutes), 1991. Figenshau, R.S., Clayman, R.V., Kavoussi, L.R., Chandhoke, P.S., and Albala, D.M.,: Laparoscopic Nephrectomy, (12 minutes), 1990. Kavoussi, L.R., Clayman, R.V., Albala, D.M, Chandhoke, P.S., Figenshau, R.S, and Stone, A.M., Laparoscopic Nephrectomy, (10 minutes), 1990. Albala, D.M., Chandhoke, P.J., Figenshau, R.S., and Clayman, R.C.: Clinical Applications of Flexible Ureteronephroscopy (11 minutes) 1990.
  36. 36. OPERATIVE DEMONSTRATIONS: St. Petersburg Hospital, St. Petersburg, Florida—Laparoscopic Hand-Assisted Nephrectomy, December 2002 Baptist Hospital, Louisville, Kentucky—Laparoscopic Hand-Assisted Nephrectomy, November 2002 Champlain Valley Physician’s Hospital, Plattsburg, New York—Laparoscopic Hand- Assisted Nephrectomy, May 2002. Louisville General Hospital, Louisville, Kentucky—Laparoscopic Hand-Assisted Nephrectomy, May, 2002 Medical College of Virginia, Richmond, Virginia—Laparoscopic Hand-Assisted Nephrectomy, April, 2002 All India Institute of Medical Sciences, New Delhi, India—Laparoscopic Hand-Assisted Nephrectomy, April, 2002 Singapore General Hospital, Singapore - Laparoscopic Hand-Assisted Nephrectomy, September, 2001 University of Ribeirao Preto, Brazil – Laparoscopic Hand-Assisted Nephrectomy, July, 2001. Keesler Air Force Hospital, Biloxi, Mississippi – Bilateral Laparoscopic Hand-Assisted Nephrectomy, July, 2001. Ankara General Hospital, Ankara, Turkey – Accucise Endopyelotomy, May,2001. Caligary Hospital, Caligary, Sardenia, Italy – Laparoscopic Hand-Assisted Nephrectomy, Accuccise Endopyelotomy, May, 2001. Peoria Medical Center, Peoria, Illinois - Laparoscopic Hand-Assisted Nephrectomy, January, 2001. Iceland Urological Association, Reykjavik, Iceland - Laparoscopic Hand- Assisted Nephrectomy, October, 2000. 18th World Congress on Endourology and ESWL 16th Basic Research Symposium, Sao Paolo, Brazil- Acucise Endopyelotomy, September, 2000. Rhine Medical Center, Lepitz Germany - Laparoscopic Andrenalectomy, June, 2000.
  37. 37. Coimbatore Urological Association, Coimbatore, India - Laparoscopic Hand-Assisted Nephrectomy, June, 2000. All India Institute of Medical Sciences, New Delhi, India - Laparoscopic Hand-Assisted Nephrectomy, November, 1999. Lake Charles Medical Center, Lake Charles, Louisiana - Laparoscopic Adrenalectomy, July, 1999. San Diego Naval Hospital, San Diego, California - Laparoscopic Hand-Assisted Nephrectomy, July, 1999. Panipat Medical Center, Panipat, India - Ureteroscopy, Percutaneous Nephrolithotomy, December, 1998. All India Institute of Medical Sciences, New Delhi, India - Ureteroscopy, Endopyelotomy, December, 1998. Christian Medical College and Hospital, Vellore, India - Ureteroscopy, Endopyelotomy, Laparoscopic Nephrectomy, December, 1998. Tulane University Medical Center, New Orleans, Louisiana - Laparoscopic Adrenalectomy, October, 1997. George Washington University Medical Center, Washington D.C. - Laparoscopic Nephrectomy, April, 1996. Cornell University/New York Hospital, New York, New York - Laparoscopic Adrenalectomy, December, 1995. National Institute of Health, Bethesda, Maryland - Laparoscopic Adrenalectomy, March, 1995. Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire - Laparoscopic Pelvic Lymph Node Dissection, October 1994. Medical College of Wisconsin, Milwaukee, Wisconsin - Laparoscopic Pelvic Lymph Node Dissection, September, 1994. Hospital La Fe, Barcelona, Spain - Laparoscopic Nephrectomy, September, 1992. University of California at San Diego, San Diego, California - Ureteroscopy, Laparoscopic Pelvic Lymph Node Dissection, October, 1992. Cochin Hospitaux, Paris, France - Laparoscopic Nephrectomy, September, 1992.
  38. 38. Massachusetts General Hospital, Boston, Massachusetts - Laparoscopic Nephrectomy, August, 1992. INVITED PRESENTATIONS: Duke Winter Urologic Forum, Steamboat Springs, Colorado, February, 2003. 14th Annual Urology Symposium, Fort Lauderdale, Flordia, February, 2003. International College of Surgeons Meeting, Taipei, China, November, 2002. 20th World Congress on Endourology and ESWL, Geneva, Italy, October 2002. New York American Urological Association Annual Meeting, Madrid, Spain, September, 2002. All India Institute of Medical Science, New Delhi, India, April, 2002. Mexican Urological Association Annual Meeting, Mexico City, Mexico, February 2002. 19th World Congress on Endourology and ESWL, Bangkok, Thailand, November 2001. Singapore General Hospital, Singapore, September, 2001. Society of Pelvic Surgeons, Oslo, Norway, July, 2001. University of Rebeirao Preto, Rebeirao Preto, Brazil, July, 2001. 96th American Urological Association Annual Meeting, Anaheim, California, June, 2001. Ankara Urological Association, Ankara, Turkey, May, 2001. Italian Urological Association, Caligary (Sardinia), Italy, May 2001. Henry Ford Hospital (Grand Rounds), Detroit, Michigan, March 2001 Wayne State University (Grand Rounds), Detroit, Michigan, March 2001 Fourth International Symposium on Urology, Nephrology and Transplantation, Sindh Institute of Urology and Transplantation, Karachi, Pakistan, February, 2001. 48th Annual James C. Kimbrough Urological Seminar, San Diego, California, January, 2001. Societe of International Urology, Singapore, November, 2000.
  39. 39. The Mellineum Urological Meeting, Delhi, India, November, 2000. The 27th Annual Egyptian Urological Meeting, Cairo, Egypt, October, 2000. Iceland Urological Association, Reykjavik, Iceland, October, 2000. 18th World Congress on Endourology and ESWL, Sao Paolo, Brazil, September, 2000. Coimbatore Urological Association, Coimbatore, India, June, 2000. 95th American Urological Associates Annual Meeting, Atlanta, Georgia, May, 2000. Video Urology 2000: 12th World Congress of Videourology, Goa, India, March, 2000. All India Institute of Medical Sciences, New Delhi, India, November, 1999. Kentucky Urological Association , Louisville, Kentucky, November, 1999. Circon/ACMI Annual Meeting, Tampa, Florida, November, 1999. 17th World Congress of Endourology of Shock Wave Lithotripsy, Athens, Greece, September 1999. Specialty Review in Urology, Chicago, Illinois, April 1993, 1994, 1995, 1996, 1997,1998, 1999, 2000, 2001. Timely Topics in Urology, Loyola University, Maywood, Illinois, June 1999. 94th American Urologic Association Annual Meeting, Dallas, Texas, April, 1999. 23rd Annual James McDonald Urological Seminar, Scottsdale, Arizona, March 1999. University of Miami, Challenging Cases in Urology, Miami Florida, February, 1999. All India Institute of Medical Sciences, New Delhi, India, December, 1998. Christian Medical College and Hospital, Vellore, India, December, 1998. 16th World Congress of Endourology of Shock Wave Lithotripsy, New York, New York, September, 1998 Wayne State University Grand Rounds, Detroit, Michigan, August, 1998. Mississippi/Alabama Urological Society Meeting, Biloxi, Mississippi, August, 1998. 93rd American Urological Association Annual Meeting, San Diego, California, May 1998
  40. 40. Tampa Urological Association Meeting, Tampa, Florida, March, 1998. American College of Surgeons 84th Clinical Congress, American College of Surgeons, Orlando, Florida, October, 1998. 15th World Congress of Endourology and Shock Wave Lithotripsy, Edinburgh, Scotland, September, 1997. 92nd American Urologist Association Annual Meeting, New Orleans, Louisiana, April, 1997. The 44th Annual James C. Kimbrough Urological Seminar, Scottsdale, Arizona, December, 1996. The 1st International Pan Arab Endolaparoscopic Urology Congress, Cairo, Egypt, November, 1996. 14th World Congress of Endourology and Shock Wave Lithotripsy, Melbourne, Australia, November, 1996. American College of Surgeons - 82nd Clinical Congress, American College of Surgeons, San Francisco, California, October, 1996. North Central American Urological Association Annual Meeting, Tucson, Arizona, September, 1996. Alumni Meeting of the White House Fellows, Annapolis, Maryland, June, 1996 George Washington University Trauma Lecture, Washington DC, February, 1996. University of California San Diego - Tissue Sealants: Current Practice, Future Uses. San Diego, California, April, 1995. Uniformed Services University of the Health Sciences - Potential Uses of Fibrin Sealants, Bethesda, Maryland, December, 1994. 13th World Congress of Endourology and Shock Wave Lithotripsy, Jerusalem, Israel, November, 1995. Alf H. Gunderson Memorial Lecture, Gunderson Clinic, LaCrosse, Wisconsin, September, 1995 90th American Urological Association Meeting, Las Vegas, Nevada April, 1995. XII Annual Urology Conference, Gainesville, Florida, March 1995.
  41. 41. 12th World Congress of Endourology and Shock Wave Lithotripsy, St. Louis, Missouri, December 1994. American College of Surgeons - 80th Clinical Congress, Chicago, Illinois, October, 1994. North Central American Urological Association Annual Meeting, Boca Raton, Florida, September, 1994. Society of Pelvic Surgeons Annual Meeting, Chicago, Illinois, September, 1994. Basic Science Course in Urology, American Urological Association Charlottesville, Virginia, June, 1993; June, 1994; June 1995, June 1996, June 1997, June 1998, June 1999. 91st American Urological Association Meeting, San Francisco, California, May 1994. 5th Internal Meeting - Society for Minimally Invasive Therapy, Orlando, Florida, November, 1993. 11th World Congress on Endourology and ESWL, Florence, Italy, October, 1993. 35th World Congress of International Society of Surgery, Hong Kong, August 1993. Urological Association of Pennsylvania and Maryland Urological Society - New Technologies in Urology, Baltimore, Maryland June, 1993. 90th American Urological Association Meeting, San Antonio, Texas May, 1993. 17th Annual Clinical Problems in Urology, Northwestern University Chicago, Illinois, April, 1993. Society of Surgical Oncology Annual Meeting, Los Angeles, California, March, 1993. Curso Internacional - Advances in Urologia, Hospital La Fe, Barcelona, Spain, March, 1993. Minimally Invasive Surgery in Oncology Symposium, M.D. Anderson Cancer Center, Houston, Texas, December, 1992. Surgical Grand Rounds, Cornell University - New York Hospital, New York, N.Y., December, 1992. Hospital Universitario De Caracas, Caracas, Venezuela, November, 1992. Society for Minimally Invasive Therapy: 4th International Meeting, Dublin, Ireland. November, 1992.
  42. 42. American College of Surgeons - 78th Clinical Congress, New Orleans, Louisiana, October, 1992. San Diego Urological Society, San Diego, California, October, 1992. Minimally Invasive Surgery and New Technology. 2nd European Congress of Viscero - Synthesis, Luxemburg, September, 1992. 10th World Congress on Endourology and ESWL, Singapore, September, 1992. Group Hospitalier - Cochin, Hospitaux de Paris, Paris, France, June, 1992. 90th American Urological Association Annual Meeting, Washington, DC., June 1992. American Lithotripsy Society Annual Meeting, Orlando, Florida, October 1991. Society for Minimally Invasive Therapy: 3rd International Meeting, Boston, Massachusetts, June, 1991. Curso Internacional - Advances en Urologia, Hospital La Fe, Valencia, Spain, March, 1992. Videourology 91: 3rd World Congress of Videourology, Hakone, Japan, July, 1991. 9th World Congress on Endourology and ESWL, Vienna, Austriam, June 1991. 89th American Urological Association Annual Meeting, Toronto, Canada, June, 1991. International Anesthesia Research Society Meeting, San Antonio, Texas, April, 1990. Society for Medical Decision Making Boston, Massachusetts, March 1990. 88th American Urological Association Annual Meeting, New Orleans, Louisiana, May 1990. New England Section of the American Urological Association, Bermuda, October, 1988. New England Section of the American Urological Association, Montreal, Canada, October. 1997. Tri-State Meeting of the Maine, Vermont and New Hampshire Chapters of the Americal College of Surgeons, Sugarloaf, Maine, February, 1987. 1st Annual Symposium of the Abbassi Shaheed Hospital, Karachi, Pakistan, February, 1986.
  43. 43. 116th Annual American Public Health Association Meeting, Las Vegas, Nevada, November, 1986. 23rd Annual Symposium of the Jinnah Postgraduate Medical Center, Karachi, Pakistan, November, 1985.
  44. 44. Appendix C: Curriculum Vitae of Lesley Curtis DUKE UNIVERSITY MEDICAL CENTER CURRICULUM VITAE for Permanent Record and the Appointments and Promotions Committee Date Prepared: June 16, 2003 (Use “NA” for no entry and use continuation pages when necessary) Name (complete with degrees): Lesley H. Curtis, Ph.D., M.S. Primary academic appointment: Assistant Research Professor, Center for Clinical and Genetic Economics Director of CERTs Data Center Duke Clinical Research Institute, Duke University Medical Center Primary academic department (not DUAP): Medicine Secondary appointment (if any) - (department): NA Social Security number: 512-74-0681 Present academic rank and title (if any): Assistant Research Professor Date and rank of first Duke Faculty appointment: April 1, 2003 Medical Licensure: North Carolina License # NA Date of License (Month/Day/Year) NA Specialty certification(s) and dates (Month/Day/Year): NA Date of birth: August 13, 1965 Place (include city/state/country): Madison/ WI/ USA Citizen of : United States
  45. 45. Visa status (if applicable) Education: Institution Date (Year) Degree High School Topeka West High School 1983 Diploma College Washington University, B.A. 1987 B.A. Graduate or Professional School University of Rochester 1991 M.S. University of Rochester 2000 Ph.D.
  46. 46. -2- Scholarly societies (Alpha Omega Alpha, Sigma Xi, Phi Beta Kappa; etc.): NA Professional training and academic career (chronologically, beginning with first postgraduate position): Institution Position/Title Dates Federal Reserve Bank of St. Louis Systems Analyst 1986-1989 Academic Medical Center Consortium Program Director 1991-1996 University of Rochester Associate Provost 1996-2000 Duke Clinical Research Institute Director/CERTS 2000-Present Duke Clinical Research Institute Research Associate 2000-2003 Duke University School of Medicine Assistant Research Professor 2003-Present Publications: (Do not include submitted papers or papers in preparation. List separately those papers in press.) PLEASE NUMBER ALL ENTRIES SEQUENTIALLY (#1 OLDEST) 1. Nash IS, Curtis LH, and Rubin HR. (1999). Predictors of patient-reported physical and mental health 6 months after percutaneous coronary revascularization. American Heart Journal, 138:422-429. 2. Weaver CH, Buckner CD, Curtis LH, Bajwa K, Weinfurt KP, Wilson-Relyea BJ, and Schulman KA. (2002). Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy. Bone Marrow Transplant, 29:159-164. 3. Curtis LH, Phelps CE, McDermott, MP, and Rubin, HR. (2002). The value of patient-reported health status in predicting short-term outcomes after coronary artery bypass graft surgery. Medical Care, 40(11):1090-1100.
  47. 47. 4. Seils, DM, Castel, LD, Curtis, LH, and Weinfurt, KP. (2002). Welfare reform and latinas' use of perinatal health care. American Journal of Public Health, Housing and Health. 92(5):699-700. 5. Al-Khatib SM, Allen LaPointe NM, Curtis LH, Kramer JM, and Califf RM. (2003). Outpatient Prescribing of Antiarrhythmic Drugs from 1995 through 2000. American Journal of Cardiology, 91:91-94. 6. Castel LD, Timbie JW, Sendersky V, Curtis LH, Feather KA, and Schulman KA. (2003). Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated care. BMC Health Serv Res. 3(1). 7. Curtis LH, Østbye T, Sendersky V, Hutchison S, Allen LaPointe NM, Al-Khatib SM, Yasuda SU, Dans PE, Wright A, Califf RM, Woosley RL, and Schulman KA. (2003). Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. American Journal of Medicine, 114:135-141. 8. In Press Publications: 1. Sloan FA, Trogdon JG, Curtis LH, and Schulman KA. (2003). The impact of dementia on outcomes and process of care for medicare beneficiaries admitted with acute myocardial infarction. Journal of the American Geriatrics Society. Refereed journals: (Refereed journals are scientific publications that have active editorial boards and a system of critical review of all submissions for publication.) Non-refereed publications: (Non-refereed publications refer to those which do not routinely use a system of critical review prior to publication; such articles are often solicited by the publisher.) Chapters in books: 1. Rothenberg BM, Mooney C, and Curtis LH. Measures of severity of illness and comorbidity. Assessing the Health Status of Older Adults. Springer Publishing Company, Inc. New York, NY. August 1997.
  48. 48. Books: (Indicate authors or editor.) Non-authored publications: (Faculty member formally acknowledged in the publication for his/her contributions.) Other: a. Published scientific reviews (for mass distribution) b. Selected abstracts 1. Development of a method to increase power in economic analyses of multinational trials. Friedman JY, Weinfurt KP, Curtis LH, Gnanasakthy A, and Schulman KA. Quality of Care and Outcomes Research in CVD and Stroke, American Heart Association, October, 2002. 2. Physician characteristics of the Navigator trial predict average length of stay (ALOS) in acute coronary syndrome (ACS). Friedman JY, Curtis LH, Gnanasakthy A, and Schulman KA. International Society for Pharmaceutical Outcomes Research, 5th Annual European Congress, November, 2002. 3. Pharmaceutical expenditures in the elderly. Law AW, Curtis LH, and Schulman KA. Drug Information Association, 4th Annual Pharmaceutical Outcomes Research, Newport, RI, USA, October, 2002. 4. Yancy WS, Curtis LH, Schulman KA, Olsen MK, Cuffe M, Oddone G. (2003). Variations in coronary procedure utilization depending on body mass index. J Parenter Enteral Nutr 27(1):S12. c: Editorials, position, and background papers Editorials: 1. Welfare reform and Latinas’ use of perinatal health care. Seils DM, Castel LD, Curtis LH, and Weinfurt KP. Am J Public Health. 2001 Nov; 91(11):1857-64. Poster Presentations: 1. The impact of welfare reform on hospital expenditures for uncompensated care. Castel LD, Curtis LH, Timbie JW, Sendersky V, Feather KA, and Schulman KA. 2002 Annual Research Meeting of the Academy for Health Services Research and Health Policy. Washington DC, June, 2002. Panels:
  49. 49. 1. “Improving patient safety: health systems reporting, analysis, and research demonstrations.” Curtis, LH (panel participant). Agency for Healthcare Research and Quality, 2001. 2. “Maximizing the rational use of therapeutics: showcasing the centers for education and research in therapeutics (CERTs).” Curtis LH, Hennessy S, Shatin D, Chan KA. Drug Information Association, June 16-20, 2002, Chicago, IL. Invited Presentations: 1. Pooling outcomes data: The QMMI Experience. State-of-the-Art Health Outcomes Conference. Boston, MA. June, 1995. 2. Applying outcomes research to clinical practice. New England Healthcare Assembly. Boston, MA. April, 1995. 3. Measuring performance and quality in 12 academic medical centers. University of Rochester School of Medicine. Rochester, NY. March, 1995. 4. Maximizing the rational use of therapeutics: centers for education and research on therapeutics. American Public Health Association. Atlanta, GA. June, 2002. Consultant appointments: (Include US government, state, private organizations, etc.) NA Professional awards and special recognitions: NA Organizations and participation: (Offices held, committee assignments, etc.) NA Teaching responsibilities including continuing education: see attached Areas of research interests (basic and applied) - list: Pharmacoepidemiology Health Policy Outcomes Research
  50. 50. -4- External support - gifts, grants, and contracts: EXTERNAL SUPPORT Past Support PI % Effort Purpose Approx. Amount Duration N/A Present Support PI % Effort Purpose Approx. Duration Amount Kramer 9% Investigate clinical $519,480 9/29/02 – therapeutics in 9/28/07 cardiovascular medicine Califf .5% Enhance the $259,739 9/30/02 – CERTs 9/29/07 infrastructure and communications system Califf 35% Improve the $49,701 10/1/02 – detection of 3/31/03 medication prescribing errors in the ambulatory setting Califf 50% Enhance the $259,739 9/30/02 – CERTs 9/29/07 infrastructure and communications system Pending Support+ PI % Effort Purpose Approx. Duration Amount
  51. 51. Clinical activity - type of practice and estimate of time commitment: Participation in academic and administrative activities of the University and Medical Center _________________________________________________________________ _ Date Signature of Chair -5- Personal Information Faculty member’s preferred familiar name: Lesley H. Curtis Local home address: 305 Spring Garden Drive Durham, NC 27713 Local home phone # 919-806-1577 Marital status: Married Name of spouse: Brent

×